Cite
HARVARD Citation
Geisinger, J. et al. (2020). CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells. Nucleic acids research. 48 (16), pp. 9067-9081. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geisinger, J. et al. (2020). CRISPR/Cas9 treatment causes extended TP53-dependent cell cycle arrest in human cells. Nucleic acids research. 48 (16), pp. 9067-9081. [Online].